Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its wide range of generic and branded medications, has been facing headwinds in recent years. Sources close to the transaction suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international companies. A final decisio